Financing channel feed – Endpoints News

Financing channel feed

On in vivo cell therapy quest, Takeda-backed Ensoma buys a CRISPR upstart and bags $85M

3 years ago

Amgen kicks off 2023 dealmaking with busy ADC upstart Synaffix

3 years ago

WuXi inks $1.5B GSK pact, a big biobuck bet but a blip in billions lost from US unverified list

3 years ago

HighTide Therapeutics rides NASH R&D wave with a $107M raise

3 years ago

Sesen Bio pushes back after investor group attacks merger as ‘illogical’

3 years ago

Scoop: MPM backs a new checkpoint inhibitor biotech in $80M raise

3 years ago

Vividion 2.0? Ben Cravatt and Scripps team form a new chemoproteomics biotech

3 years ago

Scoop: Bing Yao’s ArriVent lining up $145M raise, after $150M debut in 2021

3 years ago

Scoop: J&J-backed Aro Biotherapeutics eyes nine-figure raise with first trial on horizon

3 years ago

Tiny IPO closes out Nasdaq's barren biotech year

3 years ago

Exclusive: In lieu of an IPO in rocky biotech market, Apnimed lines up $80M from existing investors for two PhIII trials

3 years ago

Scoop: To fund Covid-19 nasal vaccine booster, Yale spinout snags Series A

3 years ago

Startup making software for pharma manufacturing industry nets $12M+ Series A

3 years ago

Riding on positive PhIII NASH data, Madrigal raises $300M for road to FDA

3 years ago

'As the market has turned': Enveda secures $68M to move revised pipeline into the clinic in 2023

3 years ago

A NASH biotech plans $75M offering, Arrowhead nabs Amgen payment and Astria raises $115M

3 years ago

Scoop: A2 Biotherapeutics raises $62M for solid tumor cell therapies

3 years ago

Scoop: Moderna co-founder's regenerative medicine biotech nabs funds, but loses Genentech

3 years ago

Avidity clamors for $150M raise on heels of positive data readout

3 years ago

Danish biotech seeking niche vaccine edge against Pfizer snags €72M for pivotal study

3 years ago

Targeted radiotherapy biotech out of Longitude Capital raises a fresh $75M

3 years ago

Eli Lilly anticipates revenue boost in 2023 as it prepares to launch slate of new drugs

3 years ago

Wave Life Sciences to receive $170M upfront in new partnership with GSK to develop a large number of candidates

3 years ago

Chris Garabedian's Xontogeny shepherds two more companies through $60M Series A rounds

3 years ago

First page Previous page 40 41 424344 45 46 Next page Last page